RIDDHI SUTTON: Open Payments
NPI 1427553908 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 59 payments from 10 companies in 2025. Trend: 2023 $650 · 2024 $842 · 2025 $1,933
Food & beverage: $1,834Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $497 |
| ABBVIE INC. | 13 | $492 |
| Madrigal Pharmaceuticals | 2 | $292 |
| Ardelyx, Inc. | 12 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $168 |
| Phathom Pharmaceuticals, Inc. | 7 | $60 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| QOL Medical, LLC | 1 | $33 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, ENTYVIO, CREON, RINVOQ, VOQUEZNA, ZENPEP.
Industry payments across AL — which companies pay providers there.
